T-Cell Therapies - Catherine Bollard, Md | Pediatric Grand Rounds

T-Cell Therapies - Catherine Bollard, MD | Pediatric Grand Rounds

David Geffen School of Medicine at UCLA

Children’s National, UCL team wins $25M Grand Challenges award for CAR T in pediatric solid tumors

The Cancer Letter

Dr. Bollard Discusses T Cell Resistance to TGF-Beta in Lymphoma

Targeted Oncology

Improving T-cell therapy with antigen specific T-cells

VJHemOnc – Video Journal of Hematology & HemOnc

KEYNOTE: Catherine Bollard, M.D., MBChB, Children’s National Health System

The Children's Cancer Foundation, Inc.

Stanford Pediatrics Grand Rounds: CART for Tcell Malignancies

Stanford Department of Pediatrics

Training patients’ own immune cells to recognize and destroy hard-to-treat solid tumors

Children's National Hospital

ASH 2021: key upcoming data

VJHemOnc – Video Journal of Hematology & HemOnc

iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-cell therapy being trialled in kids with brain cancer

The Hospital Research Foundation Group

Kids Advanced Therapeutics Webinar - Revolutionising medicine: T-cell therapies today and beyond

Sydney Children's Hospitals Network

A Child's Guide Side Effects of CAR T-cell Therapy

Leukemia & Lymphoma Society

Treating pediatric ALL with chimeric antigen receptor (CAR) T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Rady Children's Hospital and CAR-T Cell Therapy

Thermo Fisher Scientific

Car T Therapy

Leeds Teaching Hospitals NHS Trust

Public Lecture: Immunotherapy & Cancer - The latest research

Cold Spring Harbor Laboratory

What is CAR T-cell Therapy?

Johns Hopkins All Children's Hospital

Challenges of CAR T-cell treatment in pediatric ALL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T cell therapy - Providing ground-breaking and life-saving cancer treatment

University Hospitals Bristol and Weston NHS FT